Quick Answer
AIM ImmunoTech Inc. reported Research And Development Expense of $3.92 million for the year ending 2025.
- AIM ImmunoTech Inc. showed a decrease of -36.7% in Research And Development Expense from 2024 to 2025.
- This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $1.64 million | Q2 2011: $1.62 million | Q3 2011: $1.75 million | Q1 2012: $1.67 million | Q2 2012: $1.74 million | Q3 2012: $2.36 million | Q1 2013: $2.34 million | Q2 2013: $2.32 million | Q3 2013: $2.17 million | Q1 2014: $2.33 million | Q2 2014: $2.33 million | Q3 2014: $1.89 million | Q1 2015: $2.67 million | Q2 2015: $2.44 million | Q3 2015: $1.97 million | Q1 2016: $1.00 million | Q2 2016: $900.0 thousand | Q3 2016: $1.34 million | Q1 2017: $1.39 million | Q2 2017: $1.11 million | Q3 2017: $787.0 thousand | Q1 2018: $855.0 thousand | Q2 2018: $1.34 million | Q3 2018: $1.60 million | Q1 2019: $928.0 thousand | Q2 2019: $1.10 million | Q3 2019: $1.19 million | Q1 2020: $898.0 thousand | Q2 2020: $1.46 million | Q3 2020: $1.10 million | Q1 2021: $1.42 million | Q2 2021: $1.32 million | Q3 2021: $2.01 million | Q1 2022: $1.04 million | Q2 2022: $2.48 million | Q3 2022: $1.37 million | Q1 2023: $2.05 million | Q2 2023: $2.95 million | Q3 2023: $2.73 million | Q1 2024: $1.95 million | Q2 2024: $1.15 million | Q3 2024: $1.44 million | Q1 2025: $1.08 million | Q2 2025: $1.17 million | Q3 2025: $607.0 thousand.
- Over the full 17 years of available data (2009 to 2025), AIM ImmunoTech Inc.'s Research And Development Expense has declined by 43.9%.
- Historical annual values: Fiscal year 2025: $3.92 million | Fiscal year 2024: $6.20 million | Fiscal year 2023: $10.94 million | Fiscal year 2022: $6.99 million | Fiscal year 2021: $7.67 million | Fiscal year 2020: $5.72 million | Fiscal year 2019: $4.65 million | Fiscal year 2018: $4.78 million | Fiscal year 2017: $4.10 million | Fiscal year 2016: $5.11 million | Fiscal year 2015: $8.04 million | Fiscal year 2014: $8.99 million | Fiscal year 2013: $8.36 million | Fiscal year 2012: $9.51 million | Fiscal year 2011: $6.72 million | Fiscal year 2010: $7.61 million | Fiscal year 2009: $7.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: